Ji Seon Choi

Ji Seon Choi

Auto-generated profile, based on publicly available information

Ji Seon Choi

Department of Laboratory Medicine, International St. Mary's Hospital, Catholic Kwandong University College of Medicine, Incheon, Korea

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Yonsei Medical Journal
Verified
Journal Article
Open access
JCJi Seon Choi
Ji Seon Choi
IPIkchun Park
Ikchun Park
SLSoo Jung Lee
Soo Jung Lee
JHJu Hyojin
Ju Hyojin
HLHyeyoung Lee
Hyeyoung Lee
JKJAYOUNG KIM
JAYOUNG KIM
Bone markers can be useful for the diagnosis and treatment of skeletal diseases in children and adolescents. Owing to high skeletal growth velocity and rapid bone turnover, children and adolescents have higher bone marker levels than adults. Thus, a valid age- and sex-specific reference should be established for pediatric populations living in similar environments. We aimed to assess the associations of procollagen type I N-terminal propeptide (P1NP) and osteocalcin with age and sex in a group of healthy Korean children and adolescents. The participants (290 boys and 290 girls, age range 0-18 years) were Korean outpatients. Serum P1NP and osteocalcin levels were measured in control materials and patient samples by electrochemiluminescence immunoassay using an automated Cobas e411 analyzer. Significant age-dependent variations in bone marker levels were observed in both sexes (p<0.001). The highest P1NP levels were observed during the first year of life; thereafter, levels decreased until puberty. There was no postnatal peak for osteocalcin; however, its levels remained higher than the adult reference range throughout childhood. Significant differences were observed between boys and girls (p<0.05), especially between the ages of 12 and 17 years. Cobas e411 results for P1NP showed satisfactory precision and linearity. We established reference data for P1NP and osteocalcin levels in healthy Korean children and adolescents, as the first and only study of these parameters in pre-adulthood in Korea. Cobas e411-quantified bone markers may be useful for determining bone metabolism indices.

1 January 2015 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
BJBo Kyeung Jung
Bo Kyeung Jung
GCGye-Ryung Choi
Gye-Ryung Choi
JCJung Hee Chang
Jung Hee Chang
HCHye Nan Cho
Hye Nan Cho
JHJong Jin Hyun
Jong Jin Hyun
JCJi Seon Choi
Ji Seon Choi
Jung BK, et al. Ann Lab Med. 2015 Jan;35(1):137-140. http://dx.doi.org/10.3343/alm.2015.35.1.137

24 May 2018 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Closed access
PDF file
YCYoo Na Chung
Yoo Na Chung
SCSejong Chun
Sejong Chun
MPMinh‐Trang Thi Phan
Minh‐Trang Thi Phan
MNMyung‐Hyun Nam
Myung‐Hyun Nam
BCByung Min Choi
Byung Min Choi
JCJi Seon Choi
Ji Seon Choi

1 November 2016 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
JYJung Yoon
Jung Yoon
HYHee-Jeong Youk
Hee-Jeong Youk
JCJung Hee Chang
Jung Hee Chang
MJMi-Ae Jang
Mi-Ae Jang
MNMyung-Hyun Nam
Myung-Hyun Nam
Chae Seung LimChae Seung Lim
Chae Seung Lim

30 September 2019 in Korean Journal of Medical Mycology
Verified
Journal Article
Open access
JKJAYOUNG KIM
JAYOUNG KIM
JOJunsang Oh
Junsang Oh
GSGi-Ho Sung
Gi-Ho Sung
HLHyeyoung Lee
Hyeyoung Lee
JCJi Seon Choi
Ji Seon Choi
SCSun Young Choi
Sun Young Choi
A "pathogen resource" contains information about pathogens (e.g., bacteria, fungi, viruses, and protozoa) and microbial derivatives (e.g., DNA, RNA, plasmid, clone, and cDNA). Pathogen resources are important for their potential use in healthcare research because they contain clinical and epidemiological information that is different from microbial resources. In October 2014, the "Nagoya Protocol" on access and benefit-sharing with the Convention on Biological Diversity was enacted to restrict the movement of transboundary pathogens and protect the natural pathogen resources of each country. On July 2017, the Korean Medical Fungal Pathogen Resource Bank (KMFRB) was established to secure, discover, and develop biological resources focused on medical fungi. KMFRB has since been operating under the National Culture Collection for Pathogens of the National Institute of Health based on the Act No. 13992. This report aims to provide general information regarding KMFRB and suggest efficient ways to utilize human fungal pathogen resources for clinical research.